InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30

$1.17−0.07 (-5.65%)

Close on Nov 13, 2026Market cap $84.58MP/E –Yield –

InflaRx operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2023 it was -71182.1%.

Period	Period end	Value	Change (pts)
FY2023	Dec 31, 2023	-71182.1%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IFRX.

Advertisement
300 × 250

See a number that looks wrong?